Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the reply. I agree the Walmart deal seems great.
What do you make of the dilution. The number of shares increasing from millions to 7 billion is a cold hard fact and when they increased the Authorized Share amount from millions (like a couple hundred million; I forget the exact amount) to 14,975,000,000 people were like WTF, and Matthew Moore made a statement that they were not going to dump shares but they have according to the fact that approx 7 billion shares have been dumped since that increase in Authorized shares.
Is there some kind of genius to grossly diluting the outstanding shares as a means of creating a strong business that's rewarding to initial investors?
Can anyone explain the genius to me cause it seems bad to me.
But yea Walmart distribution is great, and some vets will need hearing products so that location should do good I would think.
I also want to thank you folks. I just read this very enlightening article about the business practices of Mark Moore’s company which resulted in him loosing his license as a Hearing Aid Dispenser.
https://www.theunion.com/news/local-news/state-settles-suit-against-mcdonald-hearing-aid-centers/
especially enlightening is this 52 page compliant from the experiences of those patients/customers who felt like they got burned:
https://www.scribd.com/doc/293632191/McDonald-complaint
hmmm….
Also, what’s up with the stock structure. Goes from million to billions in a short time. Can anyone explain or justify this massive increase.
seems like a risky investment…
unless just day trading it.
All replies welcome as I'm open to all your opinions.
Thanks
Could be... We've all seen this kind of crap in the OTC arena.
Don't they already have "Hearing aid big box placement"?
Hope in a shark tank sounds pretty dicy
shit show
I agree. The IP has value, especially since USPTO granted a patent for the skin cream yesterday, however, experts are obviously not placing a really high value on that patent or others in the pipeline.
I think a BO or M&A, (like what we've been hoping for for so long), is in the works but they're not going to just give money away. Hopefully shareholders will get a fair pps.
I have OWCP fatigue.
OWC's IP has value. Feels like a M&A or BO may be coming. I hope investors get something reasonable for their shares.
We have never seen a Pandemic like this. It is unprecedented in every one of our lives. Millions of small businesses have been closed during this Pandemic. Cutting expenses during the world-wide lockdown makes sense.
Reality: USPTO mailed OWCP a patent grant today 3/31/2020.
https://portal.uspto.gov/pair/PublicPair - Search on Patent 10603301
Regardless of all the chatter, OWC keeps on doing the R&D and patent work. This speculative stock has made it through some rough times and still going strong. Gonna be huge when the work comes to fruition.
news is gonna drop and this is gonna pop
Can someone in the Sacramento area go check out these 3 stores and let the board know what's up with them? Maybe post a few pics.
Solid support level at .066 going up from here
Good article!
https://mjglobalreport.com/owc-pharmaceutical-research-corp-otcmktsowcp-2020/
Why OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Is A Promising Stock In 2020
Published 6 days ago on January 2, 2020
By Jim Bloom
In 2020, investors are looking for cannabis stocks that can deliver excellent returns following a disappointing 2019, which saw many pot stocks crash to multiyear lows. OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) stands out as a promising cannabis stock to own in 2020.
About OWC Pharmaceutical Research
The cannabis stock universe is vast, so for investors who may have just come across OWC Pharmaceutical for the first time an introduction of the company is in order.
OWC Pharmaceutical is an Israel-based cannabis research company. It is focused on research and development of cannabis-based medical products. The company’s work currently includes development of cannabis-based treatments for a variety of diseases and disorders such as multiple myeloma, psoriasis and fibromyalgia.
Moreover, OWC Pharmaceutical provides consulting services to both government and private entities in the field of medical cannabis programs.
OWC Pharmaceutical Research exited 2019 on a high note
While 2019 ended up being one of the toughest year for cannabis stocks, OWC Pharmaceutical had strong finish to the year. The stock gained 35% on December 31. Before that, the stock rose 65% on December 30. The back-to-back gains in the final days of 2019 helped OWC Pharmaceutical cut its losses for the year but also signaled improving investor sentiment on the stock heading into the new year.
OWC Pharmaceutical finished 2019 at $0.089, having pulled from a low of $0.0045 at the beginning of December.
What investors should note is that OWC Pharmaceutical is actually in the early stage of what is shaping up to be a powerful breakout, and so still there is a long runaway ahead.
Medical cannabis market presents huge revenue opportunity for OWC Pharmaceutical Research
OWC Pharmaceutical’s focus on development of cannabis-based treatments gives it an exposure to a huge revenue opportunity. The medical cannabis market is growing by leaps and bounds. The global medical cannabis market generated $11.8 billion in revenue in 2017, according to Zion Market Research estimates. The market is on course to grow to $40.9 billion in annual revenue by 2024.
OWC Pharmaceutical stands to benefit from the rapidly burgeoning global medical cannabis market with its clinically validated and patent protected cannabis-based treatments for some of the most troubling medical conditions.
Recent major developments at OWC Pharmaceutical Research
There have been several notable developments in recent months at OWC Pharmaceutical that could benefit the stock down the road. Here are some of those key developments:
OWC Pharmaceutical Research patent application accepted in the United States
OWC Pharmaceutical announced last month that the United States Patent and Trademark Office accepted its patent application for cannabis-based topical formulations for use skin conditions.
The cannabis extract formulation that OWC Pharmaceutical has sought patent protection for in the United States could offer relief to people suffering from skin conditions such as Psoriatic lesions of the face. Currently, this skin condition lacks an effective alternative topical remedy, which is why success in this area promises great rewards for OWC Pharmaceutical down the road.
OWC Pharmaceutical has already secured patents for its cannabis formulations for skin disorders in Australia and the Czech Republic. Now the company is on course for a significant boost to its intellectual property portfolio with a US patent for the formulations.
OWC Pharmaceutical Research partners with STENOCARE to develop cannabis medical products
In November, OWC Pharmaceutical teamed up with STENOCARE on a program to develop and commercialize cannabis-based medical products for a variety of conditions. The first product from the partnership is expected to launch in 2021 or 2022. That product will initially be sold in STENOCARE’s existing markets in Denmark and Ireland.
STENOCARE is a Danish company focused on cultivation, production, and supply of medical cannabis products for the global market. It will provide the raw materials that the partnership will work on to develop new cannabis treatments for specific conditions.
“STENOCARE is a strong match for OWC with its unique focus on pharma-grade production and distribution of medical cannabis in interesting markets. This is fully aligned with OWC’s approach to develop and commercialize products for millions of patients,” commented OWC Pharmaceutical CEO Mordechai Bignitz.
Bottom line
Considering OWC Pharmaceutical’s 2017 high just over $3, the stock has the potential to return 2600% from its current price. Therefore, taking into account OWC Pharmaceutical’s strong fundamentals as well, the stock stands out as an attractive comeback play in 2020.
We will be updating our subscribers as soon as we know more. For the latest updates on OWC Pharmaceutical Research, sign up below!
Disclosure: We have no position in OWC Pharmaceutical Research and have not been compensated for this article.
Can you please post a link to Big Money Mike 's twitter page?
No mention of the 1:7000 Reverse Split only 6 months ago.
"'Those who do not learn history are doomed to repeat it."
When is a single coffee store suppose to open so I can find a place to relax, and drink soothing CBD infused coffee.... WHEN???
guess what.... NEVER
You folks need to paint this damn ticker to .73 so that I can breakeven on my hella risky investment I made before the 1:7000 Reverse Split which caused the value of my shares holding to decline sharply by 95%.
Once again, the famous quote
Thanks for posting this information:
So the theory is that DGF caused the PPS to increase by 45% today??? How? Prospectus 7?
Or was it because they were dumping shares? Biggest Volume since Feb 8, 2019.
Caused by dumping???
or them DGFers were tricking folks into buying 5.6 million shares?
What did you guys think of Prospectus 7?
True that does happen.
Sounds like you got the pattern figured out, are you swing trading it?
Looks like investors liked the Prospectus Supplement No. 7 (Form 424B3) filed after the market closed yesterday.
I realize folks are still debating patents, but does anyone care to comment on the spike in volume and pps today?
Before the 1:7000 Reverse Split 6 months ago, this company was called Pocket Games, Inc. with the ticker symbol PKGM. It went to trips back in April 2016. June 2016 it went to .0001 where it ping ponged between .0001 and .0002 until 12/7/16 when it was pumped and actually got back up to .003. After that it of course was down hill with the occasional pump here and there to milk it for all it's worth finding it's way back to .0001 on 5/8/17 where it stayed with the occasional trips ping pong along the way to the inevitable reverse split on 11/21/18.
Whoever heard of a 1:7000 Reverse Split???
What is the scam you ask?
They sell a story about a new fresh start to open a chain of Coffee Shops that have CBD in the Coffee... oh and you can relax there too.
You buy shares at .04 down to .0001
They do a Reverse Split (last reverse split was 1:7000 by this guy with this company 6 months ago).
Therefore you lose almost all your shares with a holding value drop of aprox 95%
They go sit on beach for 6 months drinking margaritas hoping everyone who got screwed will just forgive and forget and move on.
Then they change the ticker symbol, enter the latest craze market like CBD this time (last time it was crypto currency), then announce how they reduced the Authorized Shares and Float in a braggadocios way in a PR and start selling shares at 4 cents again.
go CBD!!!
6 mo ago 1:7000 Reverse Split and PPS was .0001
Where do you think this thing is going? CBD Herbal coffee shops? You really believe this?
This thing is going back to trips with dumping along the way...
go ATM!!! ... I mean CBD!!!
Maybe we should keep an eye out for dilution as well.
Do you agree?
You actually think he's gonna open a single coffee store? Where is he going to get the money to do that?
I want what CBD you're using. What's it called?... "Healthy Leaf" ?
So competing against Starbucks. Genius
go CBD!!!
I can't wait to see these locations. So he's gonna have one in Florida and one in New York. He's gonna need some financing.
You don't do any DD? Okie dokie
Authorized Shares now only 5 Billion. Down from 25,000,000,000. Don't forget this great achievement. That's an 80% reduction.
I wonder how management pulled this off.
oh yea...
THIS-> https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144272236
true story
I think it's going back to trips. They always do.
"The Healthy Leaf"
go High-End CBD!!!
pure gold.
Crypto has lost some of its buzz.
...and now onto CBD
go CBD!!!
Whoever heard of a 1:7000 Reverse Split? Why not just do a 1:7000000 reverse split, or a the very least a 1:10000 Reverse Split?
I just need the PPS to get painted to .73 so I can break even.
What do you say guys, let's get it there!
go CBD!!!!
Same OTC, same scammers. Reverse Split, wash, rinse, repeat.......
go CBD!!!
Yea 1:7000 Reverse Split resulted in 80% reduction in AS and 50% in float. And this is what this company brags about. Maybe I need to find a new CBD dealer.
Yea, after a 1:7000 reverse split.
But now we got CBD to ease the pain so all good.